webleads-tracker

|
ImaBiotech website in English
|
  

News

  • ASMS 2017

    Come and meet Rima Ait-Belkacem and Jonathan Stauber to discover all our capabilities. June 4- 8, 2017, in (...)

    Read more
  • Webinar on Immuno-Oncology by Rima AIT-BELKACEM, PhD

    The webinar titled “Immuno-Oncology: Tryptophan-Kynurenine Microenvironment Tumor Metabolites Pathway Highlighted by (...)

    Read more
See all news

Letter from the President

Dr. Jonathan Stauber, PhD, MBA
CEO
ImaBiotech


Jonathan Stauber Accelerating Discovery and Driving Innovation

"I remember when we started the company by inviting investors and sponsors to join the adventure and imagine a future of the company and the technology that we would develop: 3 people, with plenty of motivation, imagination, enthusiasm, and optimism.

It was 6 years ago and now we have grown a lot to deliver an exciting and complete set of services centered on MSI (Mass Spectrometry Imaging). It makes me very proud of what the team accomplished with 200 sponsors around the globe, a state-of-the art laboratory in Europe and soon in the USA, 2 software platforms, and many patents related to imaging technology.

The team and I continue to be very excited about what we have in store for the future, while continuing to improve ourselves and the technology to deliver more robust and quicker answers to our sponsors. Things change and evolve, but our motivation, imagination, enthusiasm, and optimism have never been as high and strong for supporting our team, sponsors, and technology. Multimaging is a very good example of the type of technology we imagined a few years ago: the one we’ve developed with sponsors and partners. The platform delivers an amazing solution with imaging tools combined with cloud based data analysis software to share an overview of the results easily and in real-time, improving and accelerating drug discovery and development.”